Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Safinamide has been approved by the European Medicines Agency for the treatment of adult patients with idiopathic Parkinson’s disease as add-on therapy to a stable dose of Levodopa (L-dopa) alone or in combination with other PD drugs in patients with mid-to-late-stage fluctuating disease
The cannabinoid receptor type 1
4-dihydroxyoxolan-2-yl]methyl phosphonato}oxy)(phosphonatooxy)phosphinate
¹⁹]henicosa-1(20)
5-250 μg/kg
MMPX hioUTP tetrasodium salt Safinamide has been approved byProduct information CAS Number: 78033 08 6 Molecular Weight: 266. 30 Formula: C12H18N4O3 Chemical Name: 8 (methoxymethyl) 1 methyl 3 (2 methylpropyl) 2,3,6,7 tetrahydro 1H purine 2,6 dione Smiles: CN1C(=O)N(CC(C)C)C2N=C(COC)NC=2C1=O InChiKey: NBLBCGUCPBXKOV UHFFFAOYSA N InChi: InChI=1S C12H18N4O3 c1 7(2)5 16 10 9(11(17)15(3)12(16)18)13 8(14 10)6 19 4 h7H,5 6H2,1 4H3,(H,13,14) Technical Data Appearance: Solid Power Purity: 98% (or refer to the
US$ 29.00
US$ 70.00
US$ 69.00
US$ 5119.00
US$ 24.00
US$ 14.00
US$ 29.50
US$ 1437.00
US$ 42.00
US$ 19.00
US$ 26.50
US$ 49.00